Company Filing History:
Years Active: 2002-2003
Title: Johannis Lugtenburg: Innovator in Cephalosporin Production
Introduction
Johannis Lugtenburg is a notable inventor based in Oegstgeest, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the production of cephalosporins. With a total of 2 patents to his name, his work has had a meaningful impact on antibiotic development.
Latest Patents
Lugtenburg's latest patents focus on a process for the fermentative production of deacylated cephalosporins. The first patent discloses a method for producing N-deacylated cephalosporin compounds through the fermentative production of their 7-acylated counterparts. This innovative approach enhances the efficiency of cephalosporin production, which is crucial for antibiotic development.
Career Highlights
Throughout his career, Johannis Lugtenburg has worked with prominent companies in the pharmaceutical industry, including DSM N.V. and DSM Patents & Trademarks. His experience in these organizations has allowed him to refine his expertise in patentable processes and innovations in drug production.
Collaborations
Lugtenburg has collaborated with several professionals in his field, including Maarten Nieboer and Erik De Vroom. These partnerships have contributed to the advancement of his research and the successful development of his patented processes.
Conclusion
Johannis Lugtenburg is a distinguished inventor whose work in the fermentative production of cephalosporins has paved the way for advancements in antibiotic manufacturing. His contributions continue to influence the pharmaceutical industry positively.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.